Regarding IgG3 antibodies, pivotal in infectious diseases for bolstering viral control, activating complement, and enhancing antibody-dependent cellular cytotoxicity (ADCC) responses [21], we noted a peak at week 4, succeeded by a decline from weeks 6 to 11 (Figure 12). This evidence concerns the gene IGHG3 and infectious disease.